Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-070866
Filing Date
2025-04-02
Accepted
2025-04-02 06:15:55
Documents
7
Period of Report
2025-04-02

Document Format Files

Seq Description Document Type Size
1 6-K d913001d6k.htm 6-K 9668
2 EX-99.1 d913001dex991.htm EX-99.1 33747
3 EX-99.2 d913001dex992.htm EX-99.2 26450
4 GRAPHIC g913001g0402064844124.jpg GRAPHIC 2601
5 GRAPHIC g913001g0402065002127.jpg GRAPHIC 2601
6 GRAPHIC g913001g0402070206771.jpg GRAPHIC 1087
7 GRAPHIC g913001g63m13.jpg GRAPHIC 1436
  Complete submission text file 0001193125-25-070866.txt   82334
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25801943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)